Latest Breaking News On - Alnylam pharmaceuticals trading down - Page 5 : comparemela.com

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Cut to $210 00

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Cut to $210 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesYvonne greenstreetPushkal gargAnalyst recommendations for alnylam pharmaceuticalsKb financial partnersArcher investment corpBessemer group incNews ratings for alnylam pharmaceuticals dailyAlnylam pharmaceuticalsCantor fitzgeraldSecurities exchange commissionV square quantitative managementNeedham companyAlnylam pharmaceuticals incCapital advisors ltdRoyal bank

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Cut to $218 00

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Cut to $218 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Jeffreyv poultonWilliam blairSanfordc bernsteinPushkal gargStifel nicolausRaymond jamesAlnylam pharmaceuticals trading downCapital advisors ltdAlnylam pharmaceuticals incHedge funds weigh in on alnylam pharmaceuticalsSecurities exchange commissionNeedham companyV square quantitative managementNews ratings for alnylam pharmaceuticals dailyAlnylam pharmaceuticalsFinancial gravity asset management inc

Needham & Company LLC Reaffirms Buy Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)

Needham & Company LLC Reaffirms Buy Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Yvonne greenstreetSanfordc bernsteinPushkal gargSecurities exchange commissionNeedham companyAlnylam pharmaceuticals incCantor fitzgeraldOsaic holdings incBlueshift asset managementAlnylam pharmaceuticals trading downWells fargo companyNational pension serviceAnalyst recommendations for alnylam pharmaceuticalsAlnylam pharmaceuticalsNews ratings for alnylam pharmaceuticals dailyFree report

LPL Financial LLC Buys 925 Shares of Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY)

LPL Financial LLC raised its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,710 shares of the biopharmaceutical company’s stock after acquiring an additional 925 shares during the quarter. LPL Financial […]

Yvonne greenstreetWilliam blairPushkal gargAlnylam pharmaceuticalsConnor clark lunn investment management ltdLpl financialRoyal bankQuarter for alnylam pharmaceuticalsAlnylam pharmaceuticals trading downAlnylam pharmaceuticals profileAlnylam pharmaceuticals incVanguard personalized indexing managementNews ratings for alnylam pharmaceuticals dailySecurities exchange commissionFree reportInvestment management